heading · body

Earnings · MANAPPURAM · NBFC (gold loans + microfinance)

Manappuram — a healthy gold core, a microfinance wound, and Bain at the door

Manappuram Finance Limited

period Q1 FY26 → Q4 FY26 added 2026-06-09 score 7/10
earnings-call nbfc gold-loans microfinance MANAPPURAM india

The Pulse

Manappuram is India’s second-largest gold-loan NBFC, and the story of the past year is a tale of two companies under one roof. The gold core is thriving — assets nearly doubled to ₹49,000 crore as gold prices soared, and management deliberately cut lending yields (from 22% toward 18%) to match the market leader Muthoot and chase volume instead. But the microfinance subsidiary, Asirvad, blew a hole in the group: it posted losses across the year that management admitted exceeded “the accumulated profit of the previous 38 quarters,” dragging group return on equity down to ~7%. Now three things are converging: Asirvad is clawing back to a (one-off-aided) small profit, private-equity giant Bain Capital is set to inject capital and become a joint promoter (deal still awaiting final RBI sign-off), and a new transformation-minded CEO arrived — then went on indefinite medical leave. At ~1.8x book and 28x depressed earnings, the market is pricing a recovery that hasn’t fully arrived.

The Business

The core is simple and sound: lend short-term money against household gold jewellery the company physically holds, at a healthy spread, with low credit risk because the collateral is liquid and over-margined (average loan-to-value ~57%). Because Manappuram can’t take public deposits (it’s a non-deposit-taking NBFC), it funds itself entirely from borrowings — which nearly doubled to ₹58,000 crore as the book grew. The gold engine is genuinely strong: gold assets grew ~98% year-on-year, and its online gold loan platform — now 92% of the book — is a real edge, letting customers borrow, top up and repay remotely and giving Manappuram faster price transmission than branch-bound rivals.

Around that core sit the diversification bets that were supposed to de-risk the company and instead became the problem: microfinance (Asirvad, ~100% owned), vehicle finance, MSME loans, and affordable housing. The segment numbers tell the story bluntly — the gold business grew its profit straight through the stress, while microfinance swung from a healthy profit to a heavy loss in a single year, and the vehicle and MSME books carry ugly bad-loan ratios (~10% and ~7%). Management spent the year shrinking and cleaning these non-gold books — exiting farm equipment, pausing car loans, writing off bad vehicle loans — explicitly deferring their growth to FY27.

The defining structural event is the Bain deal: a primary capital injection (not a promoter exit) giving Bain ~9% now plus warrants taking it to ~18%, making it a joint promoter alongside founder V.P. Nandakumar. As of the latest call it still hadn’t closed — RBI has reservations about Bain controlling two NBFCs (it also owns the former Adani Capital) — and the delay matters, because capital adequacy has fallen to 21.3% as the gold book ballooned. The capital raise is now a balance-sheet need, not just optionality.

How Management Thinks

Founder Nandakumar’s tone is steady, repetitive and reassurance-heavy — leaning on words like “calibrated” and “phased,” and insisting through every quarter that “budgeted profit will be achieved despite lower yields.” His core strategic bet is contrarian and worth understanding: cutting gold-loan yields to match Muthoot, wagering that faster volume growth plus lower funding costs and a ~2-percentage-point cut in operating costs more than offset the thinner spread. An analyst challenged it directly — “in the past, cutting lending rates has not helped gold-loan growth; why are you more confident this time?” — but the volume numbers (gold AUM up ~98%) suggest it’s working so far.

On candor, management grades reasonably well, especially the new finance team. They named the cause of the FY25 collapse plainly (a ₹1,963 crore provision spike at Asirvad) rather than burying it, and the new Group CFO explicitly quantified the one-offs that flattered the latest quarter — a ₹128 crore Asirvad write-back and a ₹136 crore vehicle-loan write-off — rather than letting investors assume the turnaround was cleaner than it is. That’s the kind of disclosure you want. The persistent sore point analysts keep pressing is operating costs: Manappuram has historically run far less efficiently than Muthoot at similar productivity, and management has dodged a real post-mortem on why.

Two governance overhangs loom. First, Nandakumar’s decades-long reluctance to sell Asirvad despite the carnage (“no intention to sell it off… our plan is diversification”) — a founder’s loyalty that analysts openly question. Second, and more serious: the new CEO Deepak Reddy, hired to drive a six-point transformation and become MD once Bain closes, is on indefinite medical leave in Singapore with no firm return date. The promised FY27 strategic roadmap depends on him. That’s a live key-man risk.

Capital allocation has been defensive and appropriate to the stress: infusing ₹500 crore of equity into Asirvad to stabilise it, shrinking the troubled books, maintaining a steady ~21-23% dividend payout, and awaiting Bain’s capital to rebuild the buffer.

Where It’s Going

The trajectory is “recovery, contingent on three things landing.” Management guides gold yields to hold at 17.5-18% (the bottom, they insist), gold-loan growth to compound 20-25%, standalone return on assets to recover toward 4.25-4.5% within a year, and consolidated return on equity to climb back to 13-16% over one-to-two years (and above 15% by FY28). New RBI rules from April 2026 — higher loan-to-value on small loans, new consumption and income-generating loan products, and the removal of the branch-approval cap (enabling 500-550 new gold branches in FY27) — are tailwinds. Co-lending, now live, lets Asirvad’s branches originate gold loans in partnership with banks.

The genuine tensions are unusually concrete here: (1) Asirvad’s profitability is real but fragile — strip the one-offs and it’s still loss-making; structural proof only comes as its clean new book grows to ~75% by late FY27; (2) the Bain deal must close to restore capital adequacy; (3) the CEO’s health and the strategy roadmap that hinges on it; (4) whether the yield floor genuinely holds and operating leverage delivers the promised return recovery; and (5) the unfinished non-gold cleanup, with more write-offs possible. None is fatal, but together they make this a “show me” story.

The Four Checks

  1. Quality & moat (gate). The gold business is genuinely good — a real, if narrow, moat in the branch network, trained appraisers, brand trust, and a best-in-class online platform; credit losses are structurally low. But the consolidated entity is lower-quality than its gold core because management bolted on businesses (microfinance, vehicle, MSME) it has repeatedly proven less able to underwrite. So: a high-quality engine wrapped in a mediocre conglomerate. The moat is in the gold, not the group.

  2. Returns on incremental capital & runway. Currently poor and distorted. Group ROE is ~7% and ROCE ~8% — depressed by the microfinance losses and non-gold write-offs, not the gold book (which earns well). The standalone gold business’s ~6% ROA and the runway (India’s vast household gold stock) are attractive; the question is whether the non-gold drag is now behind it. Through-cycle, the gold core can earn high-teens ROE; the consolidated number has to prove it can get back there.

  3. Capital allocation for the stage. Mixed. Supporting Asirvad with equity and cleaning the books is defensible crisis management, and bringing in Bain’s primary capital (rather than selling promoter stock) is the right way to rebuild the buffer. But the years of capital poured into diversification that destroyed value — and the founder’s refusal to cut the microfinance arm loose despite losses exceeding nearly a decade of its profits — are legitimate marks against capital-allocation judgment. Steady dividends through a loss year are arguably questionable given the capital need.

  4. Price. Pricing a recovery, not the present. At ~1.8x book and ~28x (trough) earnings on a 7% ROE, the multiple only makes sense if you believe the ROE normalises back toward the mid-teens — which is the entire bull case. The price-to-book of 1.8x is well below Muthoot’s ~3x, a discount that fairly reflects Manappuram’s messier conglomerate, the unresolved Bain/CEO overhangs, and a weaker operating-cost record. It’s neither cheap-with-a-catalyst nor expensive; it’s a fair price for a turnaround that is real but unfinished and contingent.

Sources

  • Concall transcripts read: Q1 FY26 (Aug 2025), Q2 FY26 (Oct 2025), Q3 FY26 (Jan 2026), Q4 FY26 / full-year (May 2026).
  • Annual reports read: FY23, FY24, FY25 (high-signal sections).
  • Financial snapshot: screener.in, fetched 2026-06-09 (FY26 revenue ₹9,509 Cr, PAT ₹993 Cr, ROE 7.04%, P/E 28.6x, P/B ~1.8x, dividend yield 1.16%; promoter holding fell to 31.77% in Mar-2026 with a fresh equity issuance — consistent with the Bain transaction).
  • Research dumps (not published): vault/Sources/Earnings/Manappuram Finance Ltd/.
  • Notes: snapshot returned blank GNPA/NNPA (asset quality from concalls — standalone gold GNPA ~1.81%, vehicle ~10.4%, MSME ~7.1%, Asirvad GNPA ~4.85%). The Bain Capital deal was absent from the snapshot/AR extracts but confirmed in detail across all four concalls.